£93k
−4%vs Feb 2024Active07968607Private limited companyLondon
MITOCHONDRIAL THERAPY LTD
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
01
Summary
MITOCHONDRIAL THERAPY LTD is an active private limited company (company number 07968607) incorporated on 28 February 2012, registered in London. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest micro accounts cover the period ending 28 February 2025, showing net assets of £93k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 4% on the prior period (£97k).
Peer position · net assets
By net assets it sits in the top quarter of 435 comparable companies in London (median £2,000, upper quartile £90k).
02
Key dates
- Incorporated
- 28 February 201214 yrs ago
- Next accounts due
- 28 November 2026in 37 days
- Confirmation statement due
- 14 March 2027in 143 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
04
Financials
Not reported
Not disclosed
1
No changevs Feb 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £93k | — | — | £27k | — | — | 1 |
| 29 February 2024 | £97k | — | — | £15k | — | — | 1 |
Current ratio4.4Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
05
Filing and accounts signals
- Net assets above zeroNet assets £93,140 at 28 February 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.4
- Incorporated five or more years agoIncorporated 28 February 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
06
Ownership and control
- Ms Sheriden Dianne Dixon
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 143 days
- Next accounts duein 37 days
- Accounts period endNet assets £93k · micro accounts
- Accounts period endNet assets £97k · micro accounts
- Incorporated
08
Similar companies in London
- THLALA KOLO (UK) LTDLondon · inc. Mar 2012
- ADAMS & CO LONDON LTDLondon · inc. Feb 2012
- HNS PHARMA LIMITEDForest Hill · inc. Apr 2012
- TARA MOBILE LTDLondon · inc. Dec 2011
- AMAXA PHARMA LTDLondon · inc. Jun 2012
- AEGERION PHARMACEUTICALS LIMITEDLondon · inc. Jun 2012
All companies incorporated on 28 February 2012 · in Feb 2012.
09
Reminders for MITOCHONDRIAL THERAPY LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.